Cannabis
dosist™ Announces Strategic Domestic Expansion Bringing Dose-Controlled Cannabis Products to its Second Adult-Use Market
Leading modern wellness company dosist™ today announced the expansion of its national footprint bringing its award-winning proprietary dose-controlled device, the dose pen™, and its targeted formulations to the Nevada market.
“As a global epicenter for culture, hospitality and tourism, Nevada is rapidly accelerating to become one of the world’s biggest and most intriguing cannabis markets,” said Gunner Winston, CEO of dosist. “With 43 million tourists a year and 3 million residents, Nevada represents an exciting opportunity for dosist to inspire, educate and engage a new audience about the benefits of dose-controlled cannabis therapy.”
Since launch, dosist has been recognized as a disruptor within the health and wellness industry, named by Fast Company as one of 2018’s Top 10 Most Innovative Companies in the health sector and described by Time Magazine as “cannabis that could replace pills” on their 25 Best Inventions of 2016 list.
“We are thrilled to bring our cannabis wellness platform to another key market,” continued Winston. “Our arrival in Nevada further demonstrates our commitment to provide greater access and more choice to a growing group of consumers who are looking to naturally manage their health and happiness.”
dosist’s proprietary dose pen and six targeted formulations including bliss™, sleep™, calm™, relief™, arouse™ and passion™ are now available in Nevada at select premium retailers. Find the full list (here).
SOURCE dosist
-
Cannabis1 week ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Cannabis2 weeks ago
IM Cannabis Reports First Quarter Financial Results
-
Innocan1 week ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
-
Cannabis6 days ago
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
-
Cannabis6 days ago
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
SCHWAZZE3 days ago
Schwazze Announces First Quarter 2024 Financial Results
-
Cannabis5 days ago
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth
-
Cannabis4 days ago
Polyethylene Films Packaging Market Size to Worth USD 139.98 Bn by 2032